GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...
Asserting that India simply cannot afford to pollute its way to prosperity, the Congress on Monday said increased pollution ...
As Delhi vanishes behind a dense-grey curtain and toxic air continues to choke the National Capital Region, a new survey has ...
Asserting that India simply cannot afford to pollute its way to prosperity, the Congress on Monday said increased pollution ...
The opposition reiterated their demand to urgently discuss the issue of air pollution in Delhi and northern India. The Leader ...
A Massachusetts man in his 40s has been diagnosed with silicosis, an incurable lung disease linked to popular kitchen ...
The UCR accepts referrals from GPs, Hampshire hospitals, ambulance services, families, and patients themselves. It helps ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
GSK PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the approval of depemokimab in two indications. The London-based pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback